Additive Effects of TRAIL and Paclitaxel on Cancer Cells: Implications for Advances in Cancer Therapy

Vitamins and Hormones

Volumn 67, Issue , 2004, Pages 385-407

  Odoux, Christine ^a   Albers, Andreas ^b  

^a Division of Hematology Oncology   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; MEMBRANE PROTEIN; PACLITAXEL; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL; APOPTOSIS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; DRUG INTERACTION; HUMAN; METABOLISM; NEOPLASM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; DRUG INTERACTIONS; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR STRUCTURE; NEOPLASMS; PACLITAXEL; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3042779884     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(04)67020-8     Document Type: Article

References (81)

1. E.S Alnemri D.J Livingston D.W Nicholson G Salvesen N.A Thornberry W.W Wong J Yuan Human ICE⧸CED-3 protease nomenclature Cell 87 1996 171
2. D Amadori G.L Frassineti W Zoli C Milandri P Serra A Tienghi A Ravaioli A Gentile E Salzano Doxorubicin and paclitaxel (sequential combination) in the treatment of advanced breast cancer Oncol. (Huntingt) 11 1997 30 33
3. N Andre M Carre G Brasseur B Pourroy H Kovacic C Briand D Braguer Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells FEBS Lett. 532 2002 256 260
4. J Asakuma M Sumitomo T Asano T Asano M Hayakawa Selective Akt inactivation and tumor necrosis factor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxel Cancer Res. 63 2003 1365 1370
5. A Ashkenazi R.C Pai S Fong S Leung D.A Lawrence S.A Marsters C Blackie L Chang A.E McMurtrey A Hebert L DeForge I.L Koumenis D Lewis L Harris J Bussiere H Koeppen Z Shahrokh R.H Schwall Safety and antitumor activity of recombinant soluble Apo2 ligand J. Clin. Invest. 104 1999 155 162
6. C.P Belani Paclitaxel and docetaxel combinations in non-small cell lung cancer Chest 117 2000 144S 151S
7. K Bhalla A.M Ibrado E Tourkina C Tang M.E Mahoney Y Huang Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells Leukemia 7 1993 563 568
8. M.V Blagosklonny R Robey M.S Sheikh T Fojo Paclitaxel-induced FasL-independent apoptosis and slow (non-apoptotic) cell death Cancer Biol. Ther. 1 2002 113 117
9. F Brisdelli E Iorio A Knijn A Ferretti D Marcheggiani L Lenti R Strom F Podo A Bozzi Two-step formation of 1H NMR visible mobile lipids during apoptosis of paclitaxel-treated K562 cells Biochem. Pharmacol. 65 2003 1271 1280
10. P.A Bunn Jr. K Kelly New combinations in the treatment of lung cancer: A time for optimism Chest 117 2000 138S 143S
11. M Cuello S.A Ettenberg M.M Nau S Lipkowitz Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells Gynecol. Oncol. 81 2001 380 390
12. O Dalpiaz N al Rabi A Galfano G Martignoni V Ficarra W Artibani Small cell carcinoma of the bladder: A case report and a literature review Arch. Esp. Urol. 56 2003 197 202
13. U De Giorgi G Papiani G Severini G Fiorentini M Marangolo G Rosti High-dose chemotherapy in adult patients with germ cell tumors Cancer Control 10 2003 48 56
14. A.I Einzig E Gorowski J Sasloff P.H Wiernik Phase II trial of taxol in patients with metastatic renal cell carcinoma Cancer Invest. 9 1991 133 136
15. L.E French J Tschopp The TRAIL to selective tumor death Nat. Med. 5 1999 146 147
16. S Frese T Brunner M Gugger A Uduehi R.A Schmid Enhancement of Apo2L⧸TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inhibitory protein J. Thorac. Cardiovasc. Surg. 123 2002 168 174
17. D.A Fuchs R.K Johnson Cytologic evidence that taxol, an antineoplastic agent from Taxus brevifolia , acts as a mitotic spindle poison Cancer Treat. Rep. 62 1978 1219 1222
18. A Gadducci S Cosio S Muraca A.R Genazzani Molecular mechanisms of apoptosis and chemosensitivity to platinum and paclitaxel in ovarian cancer: Biological data and clinical implications Eur. J. Gynaecol. Oncol. 23 2002 390 396
19. V Ganansia-Leymarie P Bischoff J.P Bergerat V Holl Signal transduction pathways of taxanes-induced apoptosis Curr. Med. Chem. Anti-Canc. Agents 3 2003 291 306
20. P Giannakakou D.L Sackett Y.K Kang Z Zhan J.T Buters T Fojo M.S Poruchynsky Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization J. Biol. Chem. 272 1997 17118 17125
21. A Goncalves D Braguer G Carles N Andre C Prevot C Briand Caspase-8 activation independent of CD95⧸CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4) Biochem. Pharmacol. 60 2000 1579 1584
22. T.S Griffith W.A Chin G.C Jackson D.H Lynch M.Z Kubin Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells J. Immunol. 161 1998 2833 2840
23. T.S Griffith D.H Lynch TRAIL: A molecule with multiple receptors and control mechanisms Curr. Opin. Immunol. 10 1998 559 563
24. T.S Griffith J.M Fialkov D.L Scott T Azuhata R.D Williams N.R Wall D.C Altieri A.D Sandler Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand⧸Apo-2 ligand-mediated apoptosis in renal cell carcinoma Cancer Res. 62 2002 3093 3099
25. W Guo C Zeng F Dong W Lei Paclitaxel-induced apoptosis in osteosarcoma cell line U-2 OS Chin. Med. J. (Engl.) 115 2002 1796 1801
26. M Haber C.A Burkhart D.L Regl J Madafiglio M.D Norris S.B Horwitz Altered expression of M beta 2, the class II beta-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance J. Biol. Chem. 270 1995 31269 31275
27. P Harper Current clinical practices for ovarian cancers Semin. Oncol. 29 2002 3 6
28. S Hinz A Trauzold L Boenicke C Sandberg S Beckmann E Bayer H Walczak H Kalthoff H Ungefroren Bcl-XL protects pancreatic adenocarcinoma cells against Oncogene 19 2000 5477 5486
29. X Huang T Lin J Gu L Zhang J.A Roth L.C Stephens Y Yu J Liu B Fang Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft Gene Ther. 9 2002 1379 1386
30. A.M Ibrado C.N Kim K Bhalla Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome C and caspase-3 activity during Taxol-induced apoptosis of human AML HL-60 cells Leukemia 12 1998 1930 1936
31. M Irmler M Thome M Hahne P Schneider K Hofmann V Steiner J.L Bodmer M Schroter K Burns C Mattmann D Rimoldi L.E French J Tschopp Inhibition of death receptor signals by cellular FLIP Nature 388 1997 190 195
32. M Kavallaris D.Y Kuo C.A Burkhart D.L Regl M.D Norris M Haber S.B Horwitz Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes J. Clin. Invest. 100 1997 1282 1293
33. M.M Keane S.A Ettenberg M.M Nau E.K Russell S Lipkowitz Chemotherapy augments TRAIL-induced apoptosis in breast cell lines Cancer Res. 59 1999 734 741
34. K Kim M.J Fisher S.Q Xu W.S el Deiry Molecular determinants of response to TRAIL in killing of normal and cancer cells Clin. Cancer Res. 6 2000 335 346
35. M Leverkus M Neumann T Mengling C.T Rauch E.B Brocker P.H Krammer H Walczak Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes Cancer Res. 60 2000 553 559
36. T Lin X Huang J Gu L Zhang J.A Roth M Xiong S.A Curley Y Yu K.K Hunt B Fang Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells Oncogene 21 2002 8020 8028
37. T Lin L Zhang J Davis J Gu M Nishizaki L Ji J.A Roth M Xiong B Fang Combination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancers Mol. Ther. 8 2003 441 448
38. M MacFarlane M Ahmad S.M Srinivasula T Fernandes-Alnemri G.M Cohen E.S Alnemri Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL J. Biol. Chem. 272 1997 25417 25420
39. G Majno I Joris Apoptosis, oncosis, and necrosis. An overview of cell death Am. J. Pathol. 146 1995 3 15
40. J Mole-Bajer A.S Bajer Action of taxol on mitosis: Modification of microtubule arrangements and function of the mitotic spindle in Haemanthus endosperm J. Cell Biol. 96 1983 527 540
41. A Moliterni E Tarenzi G Capri M Terenziani A Bertuzzi G Grasselli R Agresti P Piotti M Greco B Salvadori S Pilotti F Lombardi P Valagussa G Bonadonna L Gianni Pilot study of primary chemotherapy with doxorubicin plus paclitaxel in women with locally advanced or operable breast cancer Semin. Oncol. 24 1997 S17
42. H Mueller Tumor necrosis factor as an antineoplastic agent: Pitfalls and promises Cell Mol. Life Sci. 54 1998 1291 1298
43. J.M Nabholtz A Riva Taxane⧸anthracycline combinations: Setting a new standard in breast cancer? Oncologist 6 Suppl. 3 2001 5 12
44. M Nagane G Pan J.J Weddle V.M Dixit W.K Cavenee H.J Huang Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo Cancer Res. 60 2000 847 853
45. R Nimmanapalli C.L Perkins M Orlando E O'Bryan D Nguyen K.N Bhalla Pretreatment with paclitaxel enhances apo-2 ligand⧸tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels Cancer Res. 61 2001 759 763
46. S Novello T Le Chevalier European perspectives on paclitaxel⧸platinum-based therapy for advanced non-small cell lung cancer Semin. Oncol. 28 2001 3 9
47. C Odoux A Albers A.A Amoscato M.T Lotze M.K Wong TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer Int. J. Cancer 97 2002 458 465
48. R Ofir R Seidman T Rabinski M Krup V Yavelsky Y Weinstein M Wolfson Taxol-induced apoptosis in human SKOV3 ovarian and MCF7 breast carcinoma cells is caspase-3 and caspase-9 independent Cell Death Differ. 9 2002 636 642
49. T Ohtsuka D Buchsbaum P Oliver S Makhija R Kimberly T Zhou Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK⧸p38 and mitochondrial death pathway Oncogene 22 2003 2034 2044
50. H Oyaizu Y Adachi S Taketani R Tokunaga S Fukuhara S Ikehara A crucial role of caspase 3 and caspase 8 in paclitaxel-induced apoptosis Mol. Cell. Biol. Res. Commun. 2 1999 36 41
51. J Pan G Xu S.C Yeung Cytochrome c release is upstream to activation of caspase-9, caspase-8, and caspase-3 in the enhanced apoptosis of anaplastic thyroid cancer cells induced by manumycin and paclitaxel J. Clin. Endocrinol. Metab. 86 2001 4731 4740
52. E.A Perez Paclitaxel plus nonanthracycline combinations in metastatic breast cancer Semin. Oncol. 26 1999 21 26
53. E.A Perez Doxorubicin and paclitaxel in the treatment of advanced breast cancer: Efficacy and cardiac considerations Cancer Invest. 19 2001 155 164
54. R.M Pitti S.A Marsters S Ruppert C.J Donahue A Moore A Ashkenazi Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family J. Biol. Chem. 271 1996 12687 12690
55. B Pucci L Bellincampi M Tafani V Masciullo G Melino A Giordano Paclitaxel induces apoptosis in Saos-2 cells with CD95L upregulation and Bcl-2 phosphorylation Exp. Cell Res. 252 1999 134 143
56. S Rao G.A Orr A.G Chaudhary D.G Kingston S.B Horwitz Characterization of the taxol binding site on the microtubule. 2-(m-azidobenzoyl)taxol photolabels a peptide (amino acids 217-231) of beta-tubulin J. Biol. Chem. 270 1995 20235 20238
57. R Rosell E Felip Predicting response to paclitaxel⧸carboplatin-based therapy in non-small cell lung cancer Semin. Oncol. 28 2001 37 44
58. E.K Rowinsky L.A Cazenave R.C Donehower Taxol: A novel investigational antimicrotubule agent J. Natl. Cancer Inst. 82 1990 1247 1259
59. S.N Roy S.B Horwitz A phosphoglycoprotein associated with taxol resistance in J774.2 cells Cancer Res. 45 1985 3856 3863
60. P Schneider M Thome K Burns J.L Bodmer K Hofmann T Kataoka N Holler J Tschopp TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB Immunity 7 1997 831 836
61. J.P Sheridan S.A Marsters R.M Pitti A Gurney M Skubatch D Baldwin L Ramakrishnan C.L Gray K Baker W.I Wood A.D Goddard P Godowski A Ashkenazi Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors Science 277 1997 818 821
62. M.R Sprick M.A Weigand E Rieser C.T Rauch P Juo J Blenis P.H Krammer H Walczak FADD⧸MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2 Immunity 12 2000 599 609
63. G Tan L Heqing C Jiangbo J Ming M Yanhong L Xianghe S Hong G Li Apoptosis induced by low-dose paclitaxel is associated with p53 upregulation in nasopharyngeal carcinoma cells Int. J. Cancer 97 2002 168 172
64. W.D Thomas P Hersey TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells J. Immunol. 161 1998 2195 2200
65. J Thuret-Carnahan J.L Bossu A Feltz K Langley D Aunis Effect of taxol on secretory cells: Functional, morphological, and electrophysiological correlates J. Cell Biol. 100 1985 1863 1874
66. S Tomek W Koestler P Horak T Grunt T Brodowicz I Pribill J Halaschek G Haller C Wiltschke C.C Zielinski M Krainer Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines Eur. J. Cancer 39 2003 1318 1329
67. P.A Trail D Willner A.B Bianchi A.J Henderson M.D TrailSmith E Girit S Lasch I Hellstrom K.E Hellstrom Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicin Clin. Cancer Res. 5 1999 3632 3638
68. G Tudor A Aguilera D.O Halverson N.D Laing E.A Sausville Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels Cell Death Differ. 7 2000 574 586
69. J Vansteenkiste J Vandebroek K Nackaerts C Dooms D Galdermans L Bosquee A Delobbe K Deschepper W Van Kerckhoven K Vandeurzen R Deman J.P D'Odemont L Siemons B.P Van den N Dams Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: Detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine Lung Cancer 40 2003 191 199
70. S Vignati A Codegoni F Polato M Broggini Trail activity in human ovarian cancer cells: Potentiation of the action of cytotoxic drugs Eur. J. Cancer 38 2002 177 183
71. C von Haefen T Wieder F Essmann K Schulze-Osthoff B Dorken P.T Daniel Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3⧸-8-driven mitochondrial amplification loop Oncogene 22 2003 2236 2247
72. H Walczak A Bouchon H Stahl P.H Krammer Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells Cancer Res. 60 2000 3051 3057
73. H Walczak P.H Krammer The CD95 (APO-1⧸Fas) and the TRAIL (APO-2L) apoptosis systems Exp. Cell Res. 256 2000 58 66
74. H Walczak R.E Miller K Ariail B Gliniak T.S Griffith M Kubin W Chin J Jones A Woodward T Le C Smith P Smolak R.G Goodwin C.T Rauch J.C Schuh D.H Lynch Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nat. Med. 5 1999 157 163
75. S Wang Y Lu D Ma Paclitaxel-induced apoptosis in human ovarian cancer cell line COC1 J. Tongji Med. Univ. 19 1999 124 126
76. T.L Weigel M.T Lotze P.K Kim A.A Amoscato J.D Luketich C Odoux Paclitaxel-induced apoptosis in non-small cell lung cancer cell lines is associated with increased caspase-3 activity J. Thorac. Cardiovasc. Surg. 119 2000 795 803
77. S.R Wiley K Schooley P.J Smolak W.S Din C.P Huang J.K Nicholl G.R Sutherland T.D Smith C Rauch C.A Smith Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 1995 673 682
78. B.D Williamson E.A Carswell B.Y Rubin J.S Prendergast L.J Old Human tumor necrosis factor produced by human B-cell lines: Synergistic cytotoxic interaction with human interferon Proc. Natl. Acad. Sci. USA 80 1983 5397 5401
79. M Wolfson C.P Yang S.B Horwitz Taxol induces tyrosine phosphorylation of Shc and its association with Grb2 in murine RAW 264.7 cells Int. J. Cancer 70 1997 248 252
80. C.P Yang F Galbiati D Volonte S.B Horwitz M.P Lisanti Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells FEBS Lett. 439 1998 368 372
81. H.B Zhou J.R Zhu Paclitaxel induces apoptosis in human gastric carcinoma cells World J. Gastroenterol. 9 2003 442 445